Ophthotech reported $317.22M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alimera Sciences ALIM:US $ 33.07M 1.68M
Applied Genetic Technologies AGTC:US $ 49.56M 20.97M
Cytrx CYTR:US 6.18M 2.1M
Insmed INSM:US $ 674.73M 81.41M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Novartis NOVN:VX 38.14B 906M
Ophthotech OPHT:US $ 317.22M 33.74M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M